[Studies of the relevance of the tumor marker neopterin for therapeutic decisions and follow-up of breast cancer].
The value of serum neopterin as tumour marker was verified on 104 breast cancer patients. Based on the results, neopterin cannot be recommended either for deciding treatment after primary therapy or for monitoring of breast cancer.
Hacker
I
I
Lauterbach
H
H
Kob
D
D
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D001708:Biopterins / Q000031:analogs & derivatives* / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood*; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D019798:Neopterin
D014408:Biomarkers, Tumor; D001708:Biopterins; D019798:Neopterin
Untersuchungen zur Relevanz des Tumormarkers Neopterin für die Therapieentscheidung und Verlaufskontrolle bei Mammakarzinom.